SCHEMBL7476450

SCHEMBL7476450

O=CCCN1CCN(c2ccc(Nc3ncc4ccc(O)c(C5CCCC5)c4n3)cc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 15/20 0.69
CCND1 P24385 14/20 0.69
CCNE1 P24864 9/20 0.69
CDK2 P24941 9/20 0.69
CDK1 P06493 7/20 0.69
CCNB1 P14635 7/20 0.69
JAK3 P52333 2/20 0.45
SYK P43405 2/20 0.45
AURKA O14965 1/20 0.45
CCND2 P30279 2/20 0.45
CCND3 P30281 2/20 0.45
PAK4 O96013 1/20 0.45
CCNE2 O96020 1/20 0.45
CCNA2 P20248 1/20 0.45
CCNA1 P78396 1/20 0.45
PAK1 Q13153 1/20 0.45
PKN1 Q16512 1/20 0.45
FGFR2 P21802 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7460253 0.91 CDK4 (0.72) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL7468596 0.89 CDK4 (0.68) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL7475822 0.87 CDK4 (0.74) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL7459392 0.85 CDK4 (0.66) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL7463652 0.83 CDK4 (0.55) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL7469611 0.82 CDK4 (0.69) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL6088445 0.82 CDK4 (0.79) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL7475425 0.81 CDK4 (0.61) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL6088038 0.81 CDK4 (0.70) CDK4CCND1CCNE1CDK2CDK1
SCHEMBL6088904 0.81 CDK4 (0.79) CDK4CCND1CCNE1CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP claimed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO claimed
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed